How to Get Contrave Online in Constanța
Searching for Contrave online in Constanța, Romania? While Contrave is a frequently discussed weight-loss peptide, it is not currently approved for prescription in the EU, nor is it offered by Hi-Doctor.

DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
If you're looking for Contrave online in Constanța, Romania, it's important to understand its current status. Contrave is a combination medication for weight management; however, it is not currently approved for prescription in the European Union. This means you cannot legally obtain a prescription for Contrave in Constanța or anywhere else in the EU. Furthermore, Hi-Doctor does not offer Contrave. This article will explain what Contrave is, why it isn't a standard option yet, and, more importantly, introduce you to proven, EU-approved weight-loss treatments that you can access safely through an EU-licensed doctor today.
What is Contrave, and why isn't it a normal option yet?
Contrave is a brand name for a combination of two medications: bupropion (an antidepressant) and naltrexone (used for opioid and alcohol dependence). In some countries, it is approved to help adults with obesity or who are overweight with at least one weight-related condition lose weight. The exact mechanism in weight loss is complex, but it's thought to work on appetite and cravings in the brain.
Despite its availability in other regions, Contrave has not received marketing authorization from the European Medicines Agency (EMA). This means it has not completed the rigorous evaluation process required to be prescribed and sold legally within the EU. Until the EMA approves it, any sources offering Contrave online in Constanța are operating outside legal and safety frameworks. Acquiring medications from unregulated online sources carries significant risks, including receiving counterfeit products, incorrect dosages, or substances with harmful contaminants. There is no medical oversight, and your health could be seriously jeopardized.
Proven weight-loss medications available online today
While Contrave isn't an option, several highly effective and EMA-approved medications are available for weight management. These treatments work by different mechanisms, often by mimicking natural hormones that regulate appetite and satiety, and are prescribed under medical supervision:
- Ozempic (semaglutide): Primarily for type 2 diabetes, Ozempic often leads to significant weight loss and can be prescribed off-label for weight management if medically appropriate.
- Wegovy (semaglutide): A higher-dose formulation of semaglutide, Wegovy is specifically approved for chronic weight management in adults with obesity or who are overweight with related conditions.
- Mounjaro (tirzepatide): This medication is a dual GIP and GLP-1 receptor agonist, approved for type 2 diabetes, and shows impressive weight loss in clinical trials, often prescribed off-label for weight management.
- Saxenda (liraglutide): An earlier GLP-1 receptor agonist, Saxenda is approved for chronic weight management and is administered daily.
Each of these medications requires a doctor's assessment to determine suitability, ensuring treatment is safe and effective for your individual health profile.
How to get a weight-loss prescription online in Constanța, Romania
Hi-Doctor provides a straightforward, medically supervised path to access EU-approved weight-loss medications. Here’s how it works:
- Complete an online questionnaire: Spend 2–3 minutes filling out a comprehensive medical questionnaire about your health, medical history, and weight-loss goals.
- EU-licensed doctor reviews your case: An experienced EU-licensed doctor specializing in weight management will carefully review your information to ensure the chosen treatment is safe and appropriate for you.
- REMPE prescription in <24 hours (if approved): If the doctor deems treatment appropriate, a REMPE electronic prescription (a Spanish standard valid across the EU) will be issued within 24 hours. This is delivered as a downloadable PDF to your private account and via email. If the doctor finds treatment is not appropriate, your €25 consultation fee is automatically refunded.
- Pick up at any EU pharmacy: You can then print your prescription or show it on your phone at any pharmacy in any EU country, including those in Constanța, Romania, thanks to cross-border prescription directive 2011/24/EU. The online consultation costs just 25 € flat.
Why choose Hi-Doctor over unregulated peptide sellers
Choosing Hi-Doctor means prioritizing your health and safety. Unlike unregulated online vendors selling 'research chemicals' or grey-market peptides, Hi-Doctor offers:
- EU-licensed doctors: All consultations and prescriptions are handled by qualified, EU-licensed medical professionals.
- Real, approved medications: You receive legitimate, EMA-approved medications from real pharmacies.
- Safety and traceability: Every step, from consultation to prescription, is auditable and compliant with RGPD, ensuring your data and treatment are secure.
- Proven track record: With over 50,000 patients served and a 4.8-star rating on Trustpilot, Hi-Doctor is a trusted name in online healthcare.
- No-risk consultation: The 25 € consultation fee is refunded if the doctor determines treatment is not suitable, meaning there's no financial risk to exploring your options.
Hi-Doctor continuously expands its services. If a specific treatment isn't offered today, you can register your interest at hi-doctor.ai and be notified when a specialist becomes available.
COMMON QUESTIONS
Frequently asked questions
No, Contrave is not approved by the EMA and is therefore not legally available for prescription or purchase in Spain, Romania, or any other EU country.
